These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Diagnosis, pathogenesis, and treatment of chronic spontaneous urticaria. Kaplan AP Allergy Asthma Proc; 2018 May; 39(3):184-190. PubMed ID: 29669665 [TBL] [Abstract][Full Text] [Related]
15. Expert opinion: defining response to omalizumab in patients with chronic spontaneous urticaria. Ferrer M; Boccon-Gibod I; Gonçalo M; İnalöz HS; Knulst A; Lapeere H; Parthasaradhi A; Stingl G; Tagka A; Valenzuela F; Yeung J; Thomsen SF Eur J Dermatol; 2017 Oct; 27(5):455-463. PubMed ID: 29084635 [TBL] [Abstract][Full Text] [Related]
16. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience. Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122 [TBL] [Abstract][Full Text] [Related]
17. Treatment of severely recalcitrant chronic spontaneous urticaria: a discussion of relevant issues. Wieder S; Maurer M; Lebwohl M Am J Clin Dermatol; 2015 Feb; 16(1):19-26. PubMed ID: 25452254 [TBL] [Abstract][Full Text] [Related]
18. Current and Future Approaches in Management of Chronic Spontaneous Urticaria Using Anti-IgE Antibodies. Orzan OA; Popa LG; Mihai MM; Cojocaru A; Giurcăneanu C; Dorobanțu AM Medicina (Kaunas); 2022 Jun; 58(6):. PubMed ID: 35744079 [TBL] [Abstract][Full Text] [Related]
19. Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience. Nettis E; Cegolon L; Di Leo E; Canonica WG; Detoraki A; Ann Allergy Asthma Immunol; 2018 Mar; 120(3):318-323. PubMed ID: 29508719 [TBL] [Abstract][Full Text] [Related]
20. Novel Therapeutic Approaches and Targets for Treatment of Chronic Urticaria: New Insights and Promising Targets for a Challenging Disease. Martina E; Diotallevi F; Bianchelli T; Paolinelli M; Offidani A Curr Pharm Biotechnol; 2021; 22(1):32-45. PubMed ID: 32603278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]